POISE I Pilot Study

NCT03886324 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-08-17

No results posted yet for this study

Summary

POISE I study is a feasibility study for evaluating the safety and efficacy of DCB.

Conditions

  • Intestinal Stricture

Interventions

COMBINATION_PRODUCT

GIE Medical Drug Coated Balloon

Stricture patients treated by DCB

Sponsors & Collaborators

  • GIE Medical

    lead INDUSTRY

Principal Investigators

  • Bo Shen, MD · The Cleveland Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-25
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Paraguay

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03886324 on ClinicalTrials.gov